The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Newcastle Disease Vaccine-Global Market Insights and Sales Trends 2025

Newcastle Disease Vaccine-Global Market Insights and Sales Trends 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1817309

No of Pages : 100

Ask Your Query
Synopsis
Newcastle disease is a contagious viral bird disease affecting many domestic and wild avian species; it is transmissible to humans.
Newcastle disease can be controlled by the use of vaccines. There are many Newcastle disease vaccines suitable for use in commercial chickens.
The global Newcastle Disease Vaccine market size is expected to reach US$ 396.2 million by 2029, growing at a CAGR of 3.3% from 2023 to 2029. The market is mainly driven by the significant applications of Newcastle Disease Vaccine in various end use industries. The expanding demands from the Chicken, Duck & Goose and Other, are propelling Newcastle Disease Vaccine market. Live Vaccines, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Killed Vaccines segment is estimated at % CAGR for the next seven-year period.
Market competition is intense. Merial, CEVA, QYH Biotech, Ringpu Biology and Yebio, etc. are the leader of this industry. They got about 63% market shares. Asia-Pacific is the largest consumption place, with a consumption market share nearly 56%. Following Asia-Pacific, North America is the second largest consumption place with the consumption market share of 2%.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Newcastle Disease Vaccine, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Newcastle Disease Vaccine market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Newcastle Disease Vaccine market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Newcastle Disease Vaccine sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Newcastle Disease Vaccine covered in this report include Merial, CEVA, QYH Biotech, Ringpu Biology, Yebio, Harbin Veterinary Research Institute, Merck Animal Health, DHN and Zoetis, etc.
The global Newcastle Disease Vaccine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Merial
CEVA
QYH Biotech
Ringpu Biology
Yebio
Harbin Veterinary Research Institute
Merck Animal Health
DHN
Zoetis
ChengDu Tecbond
Elanco (Lohmann)
FATRO
CAVAC
Vaksindo
Global Newcastle Disease Vaccine market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Newcastle Disease Vaccine market, Segment by Type:
Live Vaccines
Killed Vaccines
Global Newcastle Disease Vaccine market, by Application
Chicken
Duck & Goose
Other
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Newcastle Disease Vaccine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Newcastle Disease Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index
1 Newcastle Disease Vaccine Market Overview
1.1 Newcastle Disease Vaccine Product Overview
1.2 Newcastle Disease Vaccine Market Segment by Type
1.2.1 Live Vaccines
1.2.2 Killed Vaccines
1.3 Global Newcastle Disease Vaccine Market Size by Type
1.3.1 Global Newcastle Disease Vaccine Market Size Overview by Type (2018-2029)
1.3.2 Global Newcastle Disease Vaccine Historic Market Size Review by Type (2018-2023)
1.3.3 Global Newcastle Disease Vaccine Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Newcastle Disease Vaccine Sales Breakdown by Type (2018-2023)
1.4.2 Europe Newcastle Disease Vaccine Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Newcastle Disease Vaccine Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Newcastle Disease Vaccine Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Newcastle Disease Vaccine Sales Breakdown by Type (2018-2023)
2 Global Newcastle Disease Vaccine Market Competition by Company
2.1 Global Top Players by Newcastle Disease Vaccine Sales (2018-2023)
2.2 Global Top Players by Newcastle Disease Vaccine Revenue (2018-2023)
2.3 Global Top Players by Newcastle Disease Vaccine Price (2018-2023)
2.4 Global Top Manufacturers Newcastle Disease Vaccine Manufacturing Base Distribution, Sales Area, Product Type
2.5 Newcastle Disease Vaccine Market Competitive Situation and Trends
2.5.1 Newcastle Disease Vaccine Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Newcastle Disease Vaccine Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Newcastle Disease Vaccine as of 2022)
2.7 Date of Key Manufacturers Enter into Newcastle Disease Vaccine Market
2.8 Key Manufacturers Newcastle Disease Vaccine Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Newcastle Disease Vaccine Status and Outlook by Region
3.1 Global Newcastle Disease Vaccine Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Newcastle Disease Vaccine Historic Market Size by Region
3.2.1 Global Newcastle Disease Vaccine Sales in Volume by Region (2018-2023)
3.2.2 Global Newcastle Disease Vaccine Sales in Value by Region (2018-2023)
3.2.3 Global Newcastle Disease Vaccine Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Newcastle Disease Vaccine Forecasted Market Size by Region
3.3.1 Global Newcastle Disease Vaccine Sales in Volume by Region (2024-2029)
3.3.2 Global Newcastle Disease Vaccine Sales in Value by Region (2024-2029)
3.3.3 Global Newcastle Disease Vaccine Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Newcastle Disease Vaccine by Application
4.1 Newcastle Disease Vaccine Market Segment by Application
4.1.1 Chicken
4.1.2 Duck & Goose
4.1.3 Other
4.2 Global Newcastle Disease Vaccine Market Size by Application
4.2.1 Global Newcastle Disease Vaccine Market Size Overview by Application (2018-2029)
4.2.2 Global Newcastle Disease Vaccine Historic Market Size Review by Application (2018-2023)
4.2.3 Global Newcastle Disease Vaccine Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Newcastle Disease Vaccine Sales Breakdown by Application (2018-2023)
4.3.2 Europe Newcastle Disease Vaccine Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Newcastle Disease Vaccine Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Newcastle Disease Vaccine Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Newcastle Disease Vaccine Sales Breakdown by Application (2018-2023)
5 North America Newcastle Disease Vaccine by Country
5.1 North America Newcastle Disease Vaccine Historic Market Size by Country
5.1.1 North America Newcastle Disease Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Newcastle Disease Vaccine Sales in Volume by Country (2018-2023)
5.1.3 North America Newcastle Disease Vaccine Sales in Value by Country (2018-2023)
5.2 North America Newcastle Disease Vaccine Forecasted Market Size by Country
5.2.1 North America Newcastle Disease Vaccine Sales in Volume by Country (2024-2029)
5.2.2 North America Newcastle Disease Vaccine Sales in Value by Country (2024-2029)
6 Europe Newcastle Disease Vaccine by Country
6.1 Europe Newcastle Disease Vaccine Historic Market Size by Country
6.1.1 Europe Newcastle Disease Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Newcastle Disease Vaccine Sales in Volume by Country (2018-2023)
6.1.3 Europe Newcastle Disease Vaccine Sales in Value by Country (2018-2023)
6.2 Europe Newcastle Disease Vaccine Forecasted Market Size by Country
6.2.1 Europe Newcastle Disease Vaccine Sales in Volume by Country (2024-2029)
6.2.2 Europe Newcastle Disease Vaccine Sales in Value by Country (2024-2029)
7 Asia-Pacific Newcastle Disease Vaccine by Region
7.1 Asia-Pacific Newcastle Disease Vaccine Historic Market Size by Region
7.1.1 Asia-Pacific Newcastle Disease Vaccine Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Newcastle Disease Vaccine Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Newcastle Disease Vaccine Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Newcastle Disease Vaccine Forecasted Market Size by Region
7.2.1 Asia-Pacific Newcastle Disease Vaccine Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Newcastle Disease Vaccine Sales in Value by Region (2024-2029)
8 Latin America Newcastle Disease Vaccine by Country
8.1 Latin America Newcastle Disease Vaccine Historic Market Size by Country
8.1.1 Latin America Newcastle Disease Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Newcastle Disease Vaccine Sales in Volume by Country (2018-2023)
8.1.3 Latin America Newcastle Disease Vaccine Sales in Value by Country (2018-2023)
8.2 Latin America Newcastle Disease Vaccine Forecasted Market Size by Country
8.2.1 Latin America Newcastle Disease Vaccine Sales in Volume by Country (2024-2029)
8.2.2 Latin America Newcastle Disease Vaccine Sales in Value by Country (2024-2029)
9 Middle East and Africa Newcastle Disease Vaccine by Country
9.1 Middle East and Africa Newcastle Disease Vaccine Historic Market Size by Country
9.1.1 Middle East and Africa Newcastle Disease Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Newcastle Disease Vaccine Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Newcastle Disease Vaccine Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Newcastle Disease Vaccine Forecasted Market Size by Country
9.2.1 Middle East and Africa Newcastle Disease Vaccine Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Newcastle Disease Vaccine Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Merial
10.1.1 Merial Company Information
10.1.2 Merial Introduction and Business Overview
10.1.3 Merial Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Merial Newcastle Disease Vaccine Products Offered
10.1.5 Merial Recent Development
10.2 CEVA
10.2.1 CEVA Company Information
10.2.2 CEVA Introduction and Business Overview
10.2.3 CEVA Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.2.4 CEVA Newcastle Disease Vaccine Products Offered
10.2.5 CEVA Recent Development
10.3 QYH Biotech
10.3.1 QYH Biotech Company Information
10.3.2 QYH Biotech Introduction and Business Overview
10.3.3 QYH Biotech Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.3.4 QYH Biotech Newcastle Disease Vaccine Products Offered
10.3.5 QYH Biotech Recent Development
10.4 Ringpu Biology
10.4.1 Ringpu Biology Company Information
10.4.2 Ringpu Biology Introduction and Business Overview
10.4.3 Ringpu Biology Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Ringpu Biology Newcastle Disease Vaccine Products Offered
10.4.5 Ringpu Biology Recent Development
10.5 Yebio
10.5.1 Yebio Company Information
10.5.2 Yebio Introduction and Business Overview
10.5.3 Yebio Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Yebio Newcastle Disease Vaccine Products Offered
10.5.5 Yebio Recent Development
10.6 Harbin Veterinary Research Institute
10.6.1 Harbin Veterinary Research Institute Company Information
10.6.2 Harbin Veterinary Research Institute Introduction and Business Overview
10.6.3 Harbin Veterinary Research Institute Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Harbin Veterinary Research Institute Newcastle Disease Vaccine Products Offered
10.6.5 Harbin Veterinary Research Institute Recent Development
10.7 Merck Animal Health
10.7.1 Merck Animal Health Company Information
10.7.2 Merck Animal Health Introduction and Business Overview
10.7.3 Merck Animal Health Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Merck Animal Health Newcastle Disease Vaccine Products Offered
10.7.5 Merck Animal Health Recent Development
10.8 DHN
10.8.1 DHN Company Information
10.8.2 DHN Introduction and Business Overview
10.8.3 DHN Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.8.4 DHN Newcastle Disease Vaccine Products Offered
10.8.5 DHN Recent Development
10.9 Zoetis
10.9.1 Zoetis Company Information
10.9.2 Zoetis Introduction and Business Overview
10.9.3 Zoetis Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Zoetis Newcastle Disease Vaccine Products Offered
10.9.5 Zoetis Recent Development
10.10 ChengDu Tecbond
10.10.1 ChengDu Tecbond Company Information
10.10.2 ChengDu Tecbond Introduction and Business Overview
10.10.3 ChengDu Tecbond Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.10.4 ChengDu Tecbond Newcastle Disease Vaccine Products Offered
10.10.5 ChengDu Tecbond Recent Development
10.11 Elanco (Lohmann)
10.11.1 Elanco (Lohmann) Company Information
10.11.2 Elanco (Lohmann) Introduction and Business Overview
10.11.3 Elanco (Lohmann) Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Elanco (Lohmann) Newcastle Disease Vaccine Products Offered
10.11.5 Elanco (Lohmann) Recent Development
10.12 FATRO
10.12.1 FATRO Company Information
10.12.2 FATRO Introduction and Business Overview
10.12.3 FATRO Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.12.4 FATRO Newcastle Disease Vaccine Products Offered
10.12.5 FATRO Recent Development
10.13 CAVAC
10.13.1 CAVAC Company Information
10.13.2 CAVAC Introduction and Business Overview
10.13.3 CAVAC Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.13.4 CAVAC Newcastle Disease Vaccine Products Offered
10.13.5 CAVAC Recent Development
10.14 Vaksindo
10.14.1 Vaksindo Company Information
10.14.2 Vaksindo Introduction and Business Overview
10.14.3 Vaksindo Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.14.4 Vaksindo Newcastle Disease Vaccine Products Offered
10.14.5 Vaksindo Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Newcastle Disease Vaccine Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Newcastle Disease Vaccine Industrial Chain Analysis
11.4 Newcastle Disease Vaccine Market Dynamics
11.4.1 Newcastle Disease Vaccine Industry Trends
11.4.2 Newcastle Disease Vaccine Market Drivers
11.4.3 Newcastle Disease Vaccine Market Challenges
11.4.4 Newcastle Disease Vaccine Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Newcastle Disease Vaccine Distributors
12.3 Newcastle Disease Vaccine Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock